Introduction: Important advancements in pregnancy outcome have been reported in women
with antiphospholipid antibodies (aPL), despite the fact that the treatment of aPL related …

Pregnancy morbidity is part of the clinical spectrum of the antiphospholipid syndrome (APS),
a chronic autoimmune condition serologically characterized by the persistent positivity of …

Antiphospholipid syndrome is a heterogenous disorder with many pregnancy-related
complications. Despite the refinement of laboratory testing and classification criteria …

Our objective was to determine whether there is a relationship between low
antiphospholipid (aPL) antibody levels and the obstetrical complications of antiphospholipid …

Antiphospholipid syndrome (APS) is an autoimmune disease manifested by a thrombotic or
obstetrical event in the presence of antiphospholipid antibodies. Obstetrical APS was initially …

Antiphospholipid syndrome (APS) is an acquired thrombophilia with clinical manifestations
associated with the presence of antiphospholipid antibodies (aPL) in patient plasma …

Antiphospholipid Syndrome (APS) is the commonest treatable cause of recurrent
miscarriage and pharmacological treatment of pregnant patients with antiphospholipid …

Antiphospholipid syndrome (APS) is an autoimmune disease characterized by clinical
manifestations such as thrombosis and obstetric complications with documented persistence …

Anti‐phospholipid syndrome (APS) recapitulates the link between autoimmunity and
pregnancy failure: Acquired anti‐phospholipid antibodies (aPL) play a pathogenic role in …

Antiphospholipid syndrome (APS) represents a serious risk factor in pregnancy resulting in
several complications, leading to fetal loss and hemostatic complications. In this dedicated …